Search

Non-viral delivery of RNA for therapeutic T cell engineering - ScienceDirect

4.8 (468) · $ 5.00 · In stock

Non-viral delivery of RNA for therapeutic T cell engineering - ScienceDirect
Technological advances in the use of viral and non-viral vectors

Technological advances in the use of viral and non-viral vectors

Use of CRISPR/Cas9 gene editing to improve chimeric antigen

Use of CRISPR/Cas9 gene editing to improve chimeric antigen

Engineering the Delivery System for CRISPR-Based Genome Editing

Engineering the Delivery System for CRISPR-Based Genome Editing

Cationic polymers for non-viral gene delivery to human T cells -  ScienceDirect

Cationic polymers for non-viral gene delivery to human T cells - ScienceDirect

Applications and developments of gene therapy drug delivery systems for  genetic diseases - ScienceDirect

Applications and developments of gene therapy drug delivery systems for genetic diseases - ScienceDirect

Automated generation of gene-edited CAR T cells at clinical scale

Automated generation of gene-edited CAR T cells at clinical scale

Non-viral delivery of RNA for therapeutic T cell engineering

Non-viral delivery of RNA for therapeutic T cell engineering

Targeted adenovirus-mediated transduction of human T cells in

Targeted adenovirus-mediated transduction of human T cells in

Advances in engineering and synthetic biology toward improved

Advances in engineering and synthetic biology toward improved

Non-viral transfection technologies for next-generation

Non-viral transfection technologies for next-generation

Ali Dehshahri on LinkedIn: Our paper entitled  in vivo gene

Ali Dehshahri on LinkedIn: Our paper entitled in vivo gene

Life, Free Full-Text

Life, Free Full-Text

Different methods to deliver therapeutic DNA and proteins to

Different methods to deliver therapeutic DNA and proteins to

Non-viral nucleic acid delivery approach: A boon for state-of-the

Non-viral nucleic acid delivery approach: A boon for state-of-the

Non-viral siRNA delivery to T cells: Challenges and opportunities

Non-viral siRNA delivery to T cells: Challenges and opportunities